Source: Business Wire

Press Release: BioResponse Nutrients : 20/20 Launching First COVID-19 Rapid Antibody Test Authorized by FDA for Point-of-Care Use

ROCKVILLE, Md.--(BUSINESS WIRE)--20/20 BioResponse announced today that it is now accepting orders for the Assure COVID-19 IgG/IgM Rapid Test kits authorized by FDA.

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
100-250
Michael A. Zeligs's photo - Founder & CEO of BioResponse Nutrients

Founder & CEO

Michael A. Zeligs

CEO Approval Rating

70/100

Read more